GK
Gurpreet Kaur
About Gurpreet Kaur
Data last updated:
Gurpreet Kaur is a Director at Mitosis Pharmaceuticals Private Limited (since 2019). The company operates in Business Services. Mitosis Pharmaceuticals Private Limited reported revenue of ₹59,685 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mitosis Pharmaceuticals Private Limited U74999UP2016PTC088532 | Director | 09 Jan 2019 | 2016 | ₹59,685 (FY 2025) | Active |
Board colleagues of Gurpreet Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amar Jeet Singh | 07682966 | Mitosis Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gurpreet Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurpreet Kaur
Gurpreet Kaur currently holds 1 directorship: Mitosis Pharmaceuticals Private Limited (Director, since 09 Jan 2019, revenue ₹59,685 (FY 2025)).
Gurpreet Kaur was first appointed on 09 Jan 2019 as Director at Mitosis Pharmaceuticals Private Limited.
The current boards of Gurpreet Kaur's companies include Amar Jeet Singh (Mitosis Pharmaceuticals Private Limited).